{"id":51442,"date":"2023-09-20T09:21:39","date_gmt":"2023-09-20T09:21:39","guid":{"rendered":"https:\/\/medsname.com\/arkamin\/"},"modified":"2026-09-12T04:33:28","modified_gmt":"2026-09-12T04:33:28","slug":"arkamin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/arkamin\/","title":{"rendered":"Arkamin"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 0 0 24px 0; border-radius: 4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin: 0 0 8px 0; font-size: 16px; font-weight: bold;\">\u26a1 Quick Answer \u2014 What is Arkamin?<\/h3>\n<p style=\"margin: 0;\"><strong>Arkamin<\/strong> je <strong>100 mcg tableta Clonidinu<\/strong> from Torrent Pharma \u2014 a <strong>centr\u00e1ln\u011b p\u016fsob\u00edc\u00ed agonista alfa-2 adrenergn\u00edch receptor\u016f (imidazolin), kter\u00fd sni\u017euje sympatick\u00fd v\u00fddej<\/strong>, p\u016fsob\u00ed na <strong>presynaptick\u00e9 alfa-2 adrenergn\u00ed receptory (a imidazolin-1 receptory) v rostr\u00e1ln\u00ed ventrolater\u00e1ln\u00ed medulle<\/strong>. Clonidin byl uveden na trh spole\u010dnost\u00ed Boehringer Ingelheim v roce 1966 jako <strong>Catapres<\/strong>. P\u016fvodn\u011b syntetizov\u00e1n jako nosn\u00ed dekongestant, n\u00e1hodn\u00e9 pozorov\u00e1n\u00ed v\u00fdrazn\u00e9 hypotenze u dobrovoln\u00edka v klinick\u00e9 studii vedlo k jeho p\u0159e\u0159azen\u00ed jako antihypertenziva. Modern\u00ed pou\u017eit\u00ed zahrnuje hypertenzi (\u010dtvrt\u00e1 linie a hypertenzn\u00ed urgentn\u00ed stavy), <strong>ADHD<\/strong> (schv\u00e1leno FDA v USA jako Kapvay ER), <strong>abstinen\u010dn\u00ed p\u0159\u00edznaky opioid\u016f a nikotinu<\/strong>, vazomotorick\u00e9 p\u0159\u00edznaky menopauzy, Tourett\u016fv syndrom, adjuvans p\u0159i bolesti (intratek\u00e1ln\u00ed) a p\u0159edopera\u010dn\u00ed medikaci. Polo\u010das 12-16 hodin (peror\u00e1ln\u011b); 20-24 hodin (transderm\u00e1ln\u00ed n\u00e1plast); n\u00e1stup \u00fa\u010dinku 30-60 minut (peror\u00e1ln\u011b); maxim\u00e1ln\u00ed plazmatick\u00e1 koncentrace 1-3 hodiny; antihypertenzn\u00ed \u00fa\u010dinek 2-4 hodiny; doba trv\u00e1n\u00ed 8-12 hodin. Hlavn\u00ed indikace: <strong>rezistentn\u00ed nebo \u010dtvrt\u00e1 linie hypertenze, hypertenzn\u00ed urgentn\u00ed stav (peror\u00e1ln\u00ed\/sublingu\u00e1ln\u00ed), ADHD, abstinen\u010dn\u00ed p\u0159\u00edznaky opioid\u016f\/nicotinu, n\u00e1valy horka v menopauze, bolest a anestetick\u00e9 dopl\u0148ky<\/strong>. Typick\u00e9 d\u00e1vkov\u00e1n\u00ed: <strong>Chronick\u00e1 hypertenze:<\/strong> 100 mcg (0,1 mg) dvakr\u00e1t a\u017e t\u0159ikr\u00e1t denn\u011b, s titrac\u00ed na obvykl\u00e9 maximum 800 mcg\/den. <strong>Nen\u00ed antihypertenzivem prvn\u00ed volby<\/strong> \u2014 reserve for fourth\/fifth-line after ACEi\/ARB, CCB, thiazide, and spironolactone. <strong>Hypertenzn\u00ed urgentn\u00ed stav (peror\u00e1ln\u00ed):<\/strong> 100-200 mcg loading dose, then 100 mcg every hour up to 600 mcg; lowers BP by 10-20% within 1-2 hours. Not for hypertensive emergency (end-organ damage) \u2014 use IV agents. <strong>Nikdy nep\u0159eru\u0161ujte u\u017e\u00edv\u00e1n\u00ed Arkaminu n\u00e1hle<\/strong> \u2014 rebound hypertension is severe and potentially life-threatening. For most hypertensive patients, modern treatment starts with an ACE inhibitor\/ARB, a calcium-channel blocker, a thiazide, and spironolactone before reaching for an alpha-blocker or centrally-acting agent.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a expedujeme je celosv\u011btov\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2014 \u017e\u00e1dn\u00e9 n\u00e1zvy l\u00e9k\u016f na vn\u011bj\u0161\u00ed stran\u011b z\u00e1silky. Platby kartou jsou zpracov\u00e1v\u00e1ny regulovan\u00fdm procesorem (v\u00fdpisy z \u00fa\u010dtu obsahuj\u00ed regulovan\u00e9ho zpracovatele plateb \u2014 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je kryta na\u0161\u00ed politikou z\u00e1ruky dod\u00e1n\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">Co je Arkamin?<\/h2>\n<p>Arkamin je peror\u00e1ln\u00ed tableta Clonidinu 100 mcg od Torrent Pharma, dod\u00e1van\u00e1 v balen\u00ed po 30-90 tablet\u00e1ch. Clonidin byl uveden na trh spole\u010dnost\u00ed Boehringer Ingelheim v roce 1966 jako <strong>Catapres<\/strong>. P\u016fvodn\u011b syntetizov\u00e1n jako nosn\u00ed dekongestant, n\u00e1hodn\u00e9 pozorov\u00e1n\u00ed v\u00fdrazn\u00e9 hypotenze u dobrovoln\u00edka v klinick\u00e9 studii vedlo k jeho p\u0159e\u0159azen\u00ed jako antihypertenziva. Modern\u00ed pou\u017eit\u00ed zahrnuje hypertenzi (\u010dtvrt\u00e1 linie a hypertenzn\u00ed urgentn\u00ed stavy), <strong>ADHD<\/strong> (schv\u00e1leno FDA v USA jako Kapvay ER), <strong>abstinen\u010dn\u00ed p\u0159\u00edznaky opioid\u016f a nikotinu<\/strong>, vazomotorick\u00e9 p\u0159\u00edznaky menopauzy, Tourett\u016fv syndrom, dopl\u0148ky bolesti (intratek\u00e1ln\u00ed) a p\u0159edmedikace p\u0159ed anestezi\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">Jak Clonidin funguje<\/h2>\n<p>Clonidin p\u016fsob\u00ed na <strong>presynaptick\u00e9 alfa-2 adrenergn\u00ed receptory (a imidazolin-1 receptory) v rostr\u00e1ln\u00ed ventrolater\u00e1ln\u00ed medulle<\/strong>. N\u00e1sledn\u00e9 \u00fa\u010dinky:<\/p>\n<ul>\n<li><strong>Sn\u00ed\u017een\u00fd centr\u00e1ln\u00ed sympatick\u00fd v\u00fdstup<\/strong> \u2014 activation of pre-synaptic alpha-2 receptors in the rostral ventrolateral medulla suppresses descending sympathetic tone to the peripheral vasculature and heart<\/li>\n<li><strong>Sn\u00ed\u017een\u00e1 hladina noradrenalinu v plazm\u011b<\/strong> \u2014 circulating catecholamines fall 30-50% within hours; heart rate drops 5-15 bpm; BP drops 10-30 mmHg<\/li>\n<li><strong>Aktivita imidazolin-1 receptor\u016f<\/strong> \u2014 an additional sympathetic-suppressing mechanism unique to imidazoline agonists (clonidine, moxonidine); may contribute to better metabolic tolerability than older centrally-acting drugs<\/li>\n<li><strong>Spin\u00e1ln\u00ed a supraspin\u00e1ln\u00ed analgetick\u00fd \u00fa\u010dinek<\/strong> \u2014 blocks pain signal relay in the dorsal horn; basis for intrathecal clonidine in chronic pain and for anaesthetic-adjunct use<\/li>\n<li><strong>Potla\u010den\u00ed noradrenergn\u00edch abstinen\u010dn\u00edch p\u0159\u00edznak\u016f<\/strong> \u2014 reduces sweating, tremor, tachycardia, and hypertension during opioid, nicotine, and alcohol withdrawal<\/li>\n<li><strong>Zlep\u0161en\u00fd tonus prefront\u00e1ln\u00ed k\u016fry<\/strong> \u2014 proposed mechanism for ADHD benefit (enhances top-down inhibitory control)<\/li>\n<li><strong>Centr\u00e1ln\u00ed anti-termoregula\u010dn\u00ed \u00fa\u010dinek<\/strong> \u2014 basis for menopausal hot-flush benefit<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Schv\u00e1len\u00e9 a v\u011bdecky podlo\u017een\u00e9 indikace<\/h2>\n<ul>\n<li><strong>Rezistentn\u00ed nebo \u010dtvrt\u00e1 linie hypertenze, hypertenzn\u00ed urgentn\u00ed stavy (peror\u00e1ln\u00ed\/sublingu\u00e1ln\u00ed), ADHD, abstinen\u010dn\u00ed p\u0159\u00edznaky od opioid\u016f\/nicotinu, menopauz\u00e1ln\u00ed n\u00e1valy, dopl\u0148kov\u00e1 l\u00e9\u010dba bolesti a anestezie<\/strong><\/li>\n<li><strong>Rezistentn\u00ed hypertenze<\/strong> (\u010dtvrt\u00e1\/p\u00e1t\u00e1 linie)<\/li>\n<li><strong>Hypertenzn\u00ed urgentn\u00ed stav<\/strong> (oral 100-200 mcg loading, then 100 mcg hourly) \u2014 not for emergency with end-organ damage<\/li>\n<li><strong>ADHD<\/strong> (schv\u00e1leno FDA jako prodlou\u017een\u00e9 uvol\u0148ov\u00e1n\u00ed Kapvay; standardn\u00ed formy s okam\u017eit\u00fdm uvoln\u011bn\u00edm se pou\u017e\u00edvaj\u00ed off-label glob\u00e1ln\u011b)<\/li>\n<li><strong>Abstinen\u010dn\u00ed p\u0159\u00edznaky od opioid\u016f a nikotinu<\/strong> \u2014 autonomic symptom relief<\/li>\n<li><strong>Menopauz\u00e1ln\u00ed vazomotorick\u00e9 p\u0159\u00edznaky (n\u00e1valy horka)<\/strong> \u2014 non-hormonal option<\/li>\n<li><strong>Tourett\u016fv syndrom<\/strong> a tikov\u00e9 poruchy<\/li>\n<li><strong>Chronick\u00e1 bolest<\/strong> \u2014 intrathecal clonidine for neuropathic or cancer pain<\/li>\n<li><strong>Anestetick\u00e1 premedikace a periopera\u010dn\u00ed t\u0159es<\/strong><\/li>\n<\/ul>\n<p><strong>Kl\u00ed\u010dov\u00e9 d\u016fkazy z klinick\u00fdch studi\u00ed:<\/strong> <strong>VA Kooperativn\u00ed studie o hypertenzi (1967-1970)<\/strong> \u2014 clonidine established as effective monotherapy in the era before ACEi, ARB, and CCB classes. <strong>Subskupinov\u00e9 anal\u00fdzy studie ALLHAT<\/strong> \u2014 clonidine-based regimens generally reduced BP equivalently to first-line classes but with worse tolerability. <strong>Pediatrick\u00e9 studie ADHD Connora a kol.<\/strong> \u2014 clonidine IR effective for hyperarousal and sleep disturbance in ADHD, though psychostimulants remain first-line. <strong>Gold et al. (1978)<\/strong> \u2014 landmark demonstration of clonidine for opiate withdrawal \u2014 abolished autonomic symptoms (sweating, piloerection, tachycardia) without cross-dependence.<\/p>\n<h2 class=\"wp-block-heading\">D\u00e1vkov\u00e1n\u00ed p\u0159\u00edpravku Arkamin<\/h2>\n<p><strong>Z\u00e1kladn\u00ed d\u00e1vka:<\/strong> <strong>Chronick\u00e1 hypertenze:<\/strong> 100 mcg (0,1 mg) dvakr\u00e1t a\u017e t\u0159ikr\u00e1t denn\u011b, s titrac\u00ed na obvykl\u00e9 maximum 800 mcg\/den. <strong>Nen\u00ed antihypertenzivem prvn\u00ed volby<\/strong> \u2014 reserve for fourth\/fifth-line after ACEi\/ARB, CCB, thiazide, and spironolactone. <strong>Hypertenzn\u00ed urgentn\u00ed stav (peror\u00e1ln\u00ed):<\/strong> 100-200 mcg loading dose, then 100 mcg every hour up to 600 mcg; lowers BP by 10-20% within 1-2 hours. Not for hypertensive emergency (end-organ damage) \u2014 use IV agents.<\/p>\n<p><strong>Dal\u0161\u00ed indikace:<\/strong> <strong>ADHD (d\u011bti a dosp\u00edvaj\u00edc\u00ed):<\/strong> 50\u2013100 mcg p\u0159ed span\u00edm zpo\u010d\u00e1tku, s postupn\u00fdm navy\u0161ov\u00e1n\u00edm na 100\u2013400 mcg\/den v rozd\u011blen\u00fdch d\u00e1vk\u00e1ch. V USA jsou preferov\u00e1ny p\u0159\u00edpravky s prodlou\u017een\u00fdm uvol\u0148ov\u00e1n\u00edm (Kapvay). <strong>Odvyk\u00e1n\u00ed od opioid\u016f (\u00faleva od autonomn\u00edch p\u0159\u00edznak\u016f):<\/strong> 100\u2013300 mcg t\u0159ikr\u00e1t a\u017e \u010dty\u0159ikr\u00e1t denn\u011b, s postupn\u00fdm sni\u017eov\u00e1n\u00edm d\u00e1vky p\u0159i odezn\u00edv\u00e1n\u00ed abstinen\u010dn\u00edch p\u0159\u00edznak\u016f. <strong>N\u00e1valy horka v menopauze:<\/strong> 50\u201375 mcg dvakr\u00e1t denn\u011b. <strong>Tourett\u016fv syndrom:<\/strong> 25\u2013100 mcg dvakr\u00e1t a\u017e t\u0159ikr\u00e1t denn\u011b. <strong>Odvyk\u00e1n\u00ed kou\u0159en\u00ed:<\/strong> 100\u2013300 mcg\/denn\u011b (peror\u00e1ln\u011b nebo transderm\u00e1ln\u011b). <strong>P\u0159edopera\u010dn\u00ed medikace:<\/strong> 200\u2013400 mcg peror\u00e1ln\u011b 60 minut p\u0159ed v\u00fdkonem.<\/p>\n<p><strong>Pod\u00e1v\u00e1n\u00ed:<\/strong> u\u017e\u00edvejte s j\u00eddlem nebo nala\u010dno; ve\u010dern\u00ed d\u00e1vky jsou vy\u0161\u0161\u00ed ne\u017e denn\u00ed, aby se sedativn\u00ed \u00fa\u010dinek p\u0159esunul do sp\u00e1nku. Nevynech\u00e1vejte d\u00e1vky (riziko rebound efektu).<\/p>\n<p><strong>Monitorovac\u00ed pl\u00e1n:<\/strong><\/p>\n<ul>\n<li><strong>Vstupn\u00ed vy\u0161et\u0159en\u00ed:<\/strong> TK vle\u017ee a vestoje (zdokumentujte ortostatick\u00fd pokles), tepov\u00e1 frekvence, EKG (screening bradykardie), seznam l\u00e9k\u016f (kontrola interakc\u00ed).<\/li>\n<li><strong>T\u00fdden 1\u20132:<\/strong> opakovan\u00e9 m\u011b\u0159en\u00ed TK (vle\u017ee a vestoje), tepov\u00e1 frekvence, hodnocen\u00ed p\u0159\u00edznak\u016f. \u00daprava d\u00e1vky podle TK a tolerance.<\/li>\n<li><strong>T\u00fdden 4\u20136:<\/strong> zhodnocen\u00ed c\u00edlov\u00e9ho TK; symptomov\u00e1 z\u00e1t\u011b\u017e; c\u00edlen\u011b se zeptejte na vynechan\u00e9 d\u00e1vky.<\/li>\n<li><strong>Pr\u016fb\u011b\u017en\u00e9:<\/strong> ro\u010dn\u00ed kontrola krevn\u00edho tlaku a srde\u010dn\u00edho stavu; nikdy nedopus\u0165te vy\u010derp\u00e1n\u00ed z\u00e1sob (riziko rebound hypertenze).<\/li>\n<li><strong>P\u0159eru\u0161it l\u00e9\u010dbu nebo sn\u00ed\u017eit d\u00e1vkov\u00e1n\u00ed p\u0159i:<\/strong> t\u011b\u017ek\u00e9 bradykardii, synkop\u011b, AV bloku druh\u00e9ho nebo t\u0159et\u00edho stupn\u011b, t\u011b\u017ek\u00e9 depresi, obt\u011b\u017euj\u00edc\u00ed sedaci bez zlep\u0161en\u00ed po 4-8 t\u00fddnech.<\/li>\n<\/ul>\n<p><strong>Ukon\u010den\u00ed l\u00e9\u010dby:<\/strong> <strong>CRITICAL \u2014 never stop clonidine abruptly.<\/strong> Rebound hypertenze s n\u00e1r\u016fstem sympatick\u00e9 aktivity se m\u016f\u017ee objevit b\u011bhem 18-36 hodin p\u0159i d\u00e1vk\u00e1ch &gt;300 mcg\/den. <strong>Postupn\u00e9 sni\u017eov\u00e1n\u00ed d\u00e1vky po dobu 2-4 t\u00fddn\u016f<\/strong>; pokud je sou\u010dasn\u011b p\u0159edeps\u00e1n beta-blok\u00e1tor, nejprve vysa\u010fte beta-blok\u00e1tor a pot\u00e9 klonidin. P\u0159i siln\u00e9 bolesti hlavy, bolesti na hrudi nebo TK &gt;180\/110 po vynech\u00e1n\u00ed nebo ukon\u010den\u00ed d\u00e1vek vyhledejte neodkladnou l\u00e9ka\u0159skou pomoc.<\/p>\n<h2 class=\"wp-block-heading\">Praktick\u00e9 pokyny pro Arkamin<\/h2>\n<ul>\n<li><strong>Rebound hypertension on abrupt discontinuation \u2014 CRITICAL, potentially life-threatening.<\/strong> Vynechan\u00e9 d\u00e1vky nebo n\u00e1hl\u00e9 ukon\u010den\u00ed mohou zp\u016fsobit n\u00e1r\u016fst sympatick\u00e9 aktivity b\u011bhem 18-36 hodin: vzestup TK o 30-50 mmHg, tachykardii, pocen\u00ed, t\u0159es a vz\u00e1cn\u011b hl\u00e1\u0161en\u00e9 p\u0159\u00edpady c\u00e9vn\u00ed mozkov\u00e9 p\u0159\u00edhody, infarktu myokardu a hypertenzn\u00ed encefalopatie. <strong>V\u017edy sni\u017eujte d\u00e1vku klonidinu postupn\u011b po dobu 2-4 t\u00fddn\u016f<\/strong> nam\u00edsto n\u00e1hl\u00e9ho ukon\u010den\u00ed. Riziko je nejvy\u0161\u0161\u00ed p\u0159i d\u00e1vk\u00e1ch &gt;300 mcg\/den a v kombinaci s beta-blok\u00e1tory.<\/li>\n<li><strong>Transderm\u00e1ln\u00ed n\u00e1plast<\/strong> (Catapres TTS, 100\/200\/300 mcg per day patches applied weekly) gives smoother plasma levels and mitigates rebound risk \u2014 useful for patients with adherence issues.<\/li>\n<li><strong>Sedace a sucho v \u00fastech<\/strong> jsou t\u00e9m\u011b\u0159 univerz\u00e1ln\u00ed p\u0159i zah\u00e1jen\u00ed l\u00e9\u010dby; obvykle \u010d\u00e1ste\u010dn\u011b ustoup\u00ed b\u011bhem 2\u20134 t\u00fddn\u016f. Hlavn\u00ed d\u00e1vku u\u017e\u00edvejte p\u0159ed span\u00edm, aby se sedace p\u0159esunula do sp\u00e1nku.<\/li>\n<li><strong>Opatrnost p\u0159i kombinovan\u00e9 terapii s betablok\u00e1tory<\/strong> \u2014 if discontinuing, stop the beta-blocker first, then taper clonidine several days later; reverse order can cause especially severe rebound because the beta-blocker blocks the compensatory reflexes.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n<p><strong>\u010cast\u00e9 (&gt;1 %):<\/strong><\/p>\n<ul>\n<li><strong>Sedace, somnolence<\/strong> (velmi \u010dast\u00e9, zejm\u00e9na prvn\u00ed 2\u20134 t\u00fddny)<\/li>\n<li><strong>Sucho v \u00fastech<\/strong> (velmi \u010dast\u00e9)<\/li>\n<li><strong>Z\u00e1vrat\u011b, ortostatick\u00e1 hypotenze<\/strong><\/li>\n<li><strong>Z\u00e1cpa<\/strong><\/li>\n<li><strong>Erektiln\u00ed dysfunkce a sn\u00ed\u017een\u00e9 libido<\/strong><\/li>\n<li><strong>Deprese, zm\u011bny n\u00e1lady<\/strong><\/li>\n<li><strong>Bradykardie, srde\u010dn\u00ed blok<\/strong> (zejm\u00e9na p\u0159i kombinovan\u00e9 terapii s beta-blok\u00e1tory nebo digoxinem)<\/li>\n<li><strong>P\u0159\u00edr\u016fstek hmotnosti, zadr\u017eov\u00e1n\u00ed sol\u00ed<\/strong> b\u011bhem n\u011bkolika m\u011bs\u00edc\u016f<\/li>\n<li><strong>Ko\u017en\u00ed reakce p\u0159i pou\u017eit\u00ed transderm\u00e1ln\u00ed n\u00e1plasti<\/strong> (kontaktn\u00ed dermatitida u 10-50 % pacient\u016f)<\/li>\n<li><strong>Poruchy sp\u00e1nku, \u017eiv\u00e9 sny, no\u010dn\u00ed m\u016fry<\/strong><\/li>\n<\/ul>\n<p><strong>Nep\u0159\u00edli\u0161 \u010dast\u00e9, ale klinicky v\u00fdznamn\u00e9:<\/strong><\/p>\n<ul>\n<li><strong>Rebound hypertenzn\u00ed krize<\/strong> on abrupt discontinuation \u2014 stroke, MI, hypertensive encephalopathy reported.<\/li>\n<li><strong>T\u011b\u017ek\u00e1 bradykardie a atrioventrikul\u00e1rn\u00ed blok<\/strong>, zejm\u00e9na p\u0159i kombinovan\u00e9 terapii s beta-blok\u00e1tory, digoxinem nebo nedihydropyridinov\u00fdmi blok\u00e1tory kalciov\u00fdch kan\u00e1l\u016f (verapamil, diltiazem).<\/li>\n<li><strong>Hlubok\u00e1 sedace<\/strong> interfering with work or driving \u2014 dose-limiting in some patients.<\/li>\n<li><strong>Deprese<\/strong> nebo zhor\u0161en\u00ed ji\u017e existuj\u00edc\u00ed deprese.<\/li>\n<li><strong>Dysfunkce sinusov\u00e9ho uzlu, synkopa<\/strong>.<\/li>\n<li><strong>T\u011b\u017ek\u00e1 alergick\u00e1 kontaktn\u00ed dermatitida p\u0159i pou\u017eit\u00ed transderm\u00e1ln\u00ed n\u00e1plasti<\/strong> \u2014 rotate sites; stop if severe.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kontraindikace<\/h2>\n<ul>\n<li>Zn\u00e1m\u00e1 p\u0159ecitliv\u011blost na klonidin<\/li>\n<li>T\u011b\u017ek\u00e1 bradyarytmie, syndrom nemocn\u00e9ho sinu, AV blok druh\u00e9ho nebo t\u0159et\u00edho stupn\u011b bez kardiostimul\u00e1toru<\/li>\n<li>T\u011b\u017ek\u00e1 deprese (relativn\u00ed kontraindikace)<\/li>\n<li>Concurrent use of other central alpha-2 agonists (methyldopa, tizanidine) \u2014 additive hypotension and sedation<\/li>\n<li>T\u011bhotenstv\u00ed: obecn\u011b se nedoporu\u010duje (preferuje se methyldopa nebo labetalol); data jsou omezen\u00e1, nen\u00ed jasn\u011b teratogenn\u00ed, ale zku\u0161enosti s alternativami jsou mnohem v\u011bt\u0161\u00ed<\/li>\n<li>Kojen\u00ed: v\u00fdznamn\u011b p\u0159ech\u00e1z\u00ed do mate\u0159sk\u00e9ho ml\u00e9ka<\/li>\n<\/ul>\n<p><strong>T\u011bhotenstv\u00ed:<\/strong> generally avoided as first-choice \u2014 methyldopa and labetalol have larger safety databases. Clonidine is not clearly teratogenic and is sometimes used as add-on therapy in resistant gestational hypertension.<\/p>\n<p><strong>Kojen\u00ed:<\/strong> significant transfer to breast milk \u2014 monitor the infant for sedation, bradycardia, and poor feeding; consider alternative agents.<\/p>\n<h2 class=\"wp-block-heading\">Interakce s l\u00e9\u010divy<\/h2>\n<ul>\n<li><strong>Beta-blockers \u2014 CRITICAL.<\/strong> Spole\u010dn\u00e1 l\u00e9\u010dba zhor\u0161uje rebound hypertenzi p\u0159i vysazen\u00ed klonidinu. Pokud jsou oba l\u00e9ky vysazov\u00e1ny sou\u010dasn\u011b, nejprve vysa\u010fte betablok\u00e1tor o n\u011bkolik dn\u00ed d\u0159\u00edve, pot\u00e9 postupn\u011b sni\u017eujte d\u00e1vku klonidinu. Betablok\u00e1tory tak\u00e9 zvy\u0161uj\u00ed riziko bradykardie v kombinaci s klonidinem.<\/li>\n<li><strong>Digoxin, nedihydropyridinov\u00e9 CCB (verapamil, diltiazem)<\/strong> \u2014 additive bradycardia and AV block.<\/li>\n<li><strong>Tricyklick\u00e1 antidepresiva a alfa-antagonist\u00e9<\/strong> \u2014 partially antagonise clonidine\u2019s antihypertensive effect; may require higher clonidine doses.<\/li>\n<li><strong>CNS depresiva (opioidy, benzodiazepiny, alkohol, gabapentinoidy)<\/strong> \u2014 aditivn\u00ed sedace.<\/li>\n<li><strong>Jin\u00e1 centr\u00e1ln\u011b p\u016fsob\u00edc\u00ed antihypertenziva (methyldopa, tizanidin, moxonidin)<\/strong> \u2014 additive sedation and hypotension; usually not combined.<\/li>\n<li><strong>Mirtazapin<\/strong> \u2014 alpha-2 antagonism reduces clonidine effect.<\/li>\n<li><strong>Diuretika<\/strong> \u2014 synergistic BP-lowering; standard combination in resistant HTN.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">M\u00edsto p\u0159\u00edpravku Arkamin v hierarchii antihypertenziv<\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 14px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u00darove\u0148<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">T\u0159\u00edda \/ P\u0159\u00edklady<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Role<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Prvn\u00ed volba<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">ACE inhibitory (<a href=\"https:\/\/medsbase.com\/cs\/ramcor\/\">ramipril<\/a>), sartany (<a href=\"https:\/\/medsbase.com\/cs\/telmaheal\/\">telmisartan<\/a>), blok\u00e1tory kalciov\u00fdch kan\u00e1l\u016f (<a href=\"https:\/\/medsbase.com\/cs\/amlode\/\">amlodipin<\/a>), thiazidy (<a href=\"https:\/\/medsbase.com\/cs\/natrilix-sr\/\">indapamid<\/a>, HCTZ)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Za\u010dn\u011bte zde u nov\u011b diagnostikovan\u00e9 hypertenze<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Druh\u00fd\/t\u0159et\u00ed l\u00e9k<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Kombinace v\u00fd\u0161e uveden\u00e9ho (ACEi+CCB, ARB+thiazid)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pokud jeden l\u00e9k nesta\u010d\u00ed<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u010ctvrt\u00fd l\u00e9k (rezistentn\u00ed hypertenze)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/cs\/aldactone\/\">Spironolakton<\/a> (d\u016fkaz z PATHWAY-2); beta-blok\u00e1tor; doxazosin<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pokud TK nen\u00ed kontrolov\u00e1n na t\u0159\u00edl\u00e9kov\u00e9 kombinaci v pln\u00e9 d\u00e1vce<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">P\u00e1t\u00fd l\u00e9k<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Alfa-blok\u00e1tory<\/strong> (<a href=\"https:\/\/medsbase.com\/cs\/prazopress\/\">prazosin<\/a>, <a href=\"https:\/\/medsbase.com\/cs\/hytrin\/\">terazosin<\/a>, doxazosin); centr\u00e1ln\u011b p\u016fsob\u00edc\u00ed l\u00e1tky<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">P\u0159idat, pokud je spironolakton nedostate\u010dn\u00fd nebo kontraindikovan\u00fd; preferujte alfa-blok\u00e1tory p\u0159i sou\u010dasn\u00e9m BPH<\/td>\n<\/tr>\n<tr style=\"background: #fff3cd;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">P\u00e1t\u00fd \/ \u0161est\u00fd l\u00e9k<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Centr\u00e1ln\u011b p\u016fsob\u00edc\u00ed l\u00e1tky<\/strong> (<a href=\"https:\/\/medsbase.com\/cs\/arkamin\/\">klonidin<\/a>, moxonidin<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">P\u0159idat k dosa\u017een\u00ed c\u00edlov\u00fdch hodnot u rezistentn\u00ed hypertenze; sledovat riziko rebound efektu a sedace<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">L\u00e9k prvn\u00ed volby v t\u011bhotenstv\u00ed<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong><a href=\"https:\/\/medsbase.com\/cs\/alphadopa\/\">Methyldopa<\/a><\/strong>, <a href=\"https:\/\/medsbase.com\/cs\/labebet\/\">labetalol<\/a>, nifedipin<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Gestan\u010dn\u00ed hypertenze a preexistuj\u00edc\u00ed hypertenze v t\u011bhotenstv\u00ed<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Skladov\u00e1n\u00ed<\/h2>\n<p>Store Arkamin below 25\u00b0C in the original blister pack. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">Pro\u010d je tak nebezpe\u010dn\u00e9 vynechat d\u00e1vky Arkaminu?<\/h3>\n<p>Clonidine suppresses central sympathetic outflow. When clonidine levels fall abruptly, the stored sympathetic drive &#8220;rebounds&#8221; within 18-36 hours \u2014 BP surges 30-50 mmHg, heart rate rises, and the patient sweats, tremors, and develops severe headache. Case reports describe rebound stroke, myocardial infarction, and hypertensive encephalopathy. This risk is greatest at doses above 300 mcg\/day and with concurrent beta-blockade. <strong>Nikdy nep\u0159est\u00e1vejte s klonidinem n\u00e1hle<\/strong> \u2014 taper over 2-4 weeks under medical supervision. Always order repeat supply 1-2 weeks before running out.<\/p>\n<h3 class=\"wp-block-heading\">Zp\u016fsob\u00ed Arkamin ospalost?<\/h3>\n<p>Yes \u2014 sedation and daytime somnolence are the most common complaints, affecting up to half of patients in the first 2-4 weeks. It usually improves substantially by week 4-6. Strategies: shift more of the daily dose to bedtime so sedation occurs during sleep; avoid alcohol and other CNS depressants; do not drive or operate machinery until you know how Arkamin affects you. If sedation remains unacceptable after 6-8 weeks, switch to an alternative (moxonidine, methyldopa in pregnancy only, or a different antihypertensive class).<\/p>\n<h3 class=\"wp-block-heading\">Mohu u\u017e\u00edvat Arkamin s alkoholem?<\/h3>\n<p>Light, occasional drinking is usually tolerated. Regular or heavy drinking substantially potentiates the orthostatic hypotension and sedation of Arkamin \u2014 falls, blackouts, and accidents become more likely. Patients at higher risk (elderly, previous falls, concurrent diuretics or sedatives) should avoid alcohol altogether on this medication.<\/p>\n<h3 class=\"wp-block-heading\">M\u016f\u017ee se Arkamin pou\u017e\u00edvat na ADHD?<\/h3>\n<p>Yes \u2014 clonidine is FDA-approved in the United States as extended-release <strong>Kapvay<\/strong> for ADHD in children and adolescents, and is used off-label (as immediate-release) internationally. It is not first-line (psychostimulants \u2014 methylphenidate, amphetamines \u2014 give larger mean effect sizes on core ADHD symptoms), but clonidine has a specific niche in hyperarousal, sleep onset, tics, and stimulant-side-effect management. Typical paediatric dose: 50-100 mcg at bedtime initially, titrating to 100-400 mcg\/day in divided doses under specialist supervision.<\/p>\n<h3 class=\"wp-block-heading\">Co kdy\u017e vynech\u00e1m d\u00e1vku?<\/h3>\n<p><strong>Vynechanou d\u00e1vku u\u017eijte co nejd\u0159\u00edve, jak si vzpomenete<\/strong>, even if it is close to the next scheduled dose \u2014 clonidine\u2019s rebound-hypertension risk means that missed doses must be replaced promptly. If you realise within 6 hours, take the missed dose and continue as normal. If more than 12 hours have passed and rebound symptoms (severe headache, palpitations, sweating) are emerging, take the dose and seek urgent medical review. Never let your supply run out \u2014 order repeat prescriptions 1-2 weeks before the current stock is exhausted.<\/p>\n<h3 class=\"wp-block-heading\">Mohu p\u0159estat u\u017e\u00edvat Arkamin, pokud m\u00e1m krevn\u00ed tlak pod kontrolou?<\/h3>\n<p><strong>Ne n\u00e1hle.<\/strong> Rebound hypertenze do 18-36 hodin po vysazen\u00ed klonidinu m\u016f\u017ee vyvolat c\u00e9vn\u00ed mozkovou p\u0159\u00edhodu, infarkt myokardu nebo hypertenzn\u00ed encefalopatii. V\u017edy sni\u017eujte d\u00e1vkov\u00e1n\u00ed postupn\u011b po dobu 2-4 t\u00fddn\u016f pod l\u00e9ka\u0159sk\u00fdm dohledem. Pokud u\u017e\u00edv\u00e1te betablok\u00e1tor, nejprve vysa\u010fte betablok\u00e1tor a a\u017e o n\u011bkolik dn\u00ed pozd\u011bji za\u010dn\u011bte s postupn\u00fdm vysazov\u00e1n\u00edm klonidinu.<\/p>\n<h3 class=\"wp-block-heading\">Mohu u\u017e\u00edvat Arkamin v t\u011bhotenstv\u00ed?<\/h3>\n<p>Generally no. Pregnancy antihypertensives of choice are methyldopa, labetalol, and nifedipine \u2014 Arkamin is not first-line in pregnancy. Switch to one of those before conception or as soon as pregnancy is confirmed, under specialist supervision.<\/p>\n<h3 class=\"wp-block-heading\">Kde lze koupit Arkamin online?<\/h3>\n<p>Arkamin (100 mcg klonidinu, 30-90 tablet) m\u016f\u017eete zakoupit na MedsBase s diskr\u00e9tn\u00edm balen\u00edm a celosv\u011btovou dopravou.<\/p>\n<h2 class=\"wp-block-heading\">Souvisej\u00edc\u00ed antihypertenziva na MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/aldactone\/\">Aldactone \u2014 Spironolactone 25\/50\/100 mg (PATHWAY-2 4th-line)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/alphadopa\/\">Alphadopa \u2014 Methyldopa 250 mg (pregnancy-safe HTN)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/hytrin\/\">Hytrin \u2014 Terazosin 1\/2\/5 mg (AbbVie)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/minipress-xl\/\">Minipress XL \u2014 Prazosin ER 2.5\/5 mg (Pfizer)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/ramcor\/\">Ramcor \u2014 Ramipril 2.5\/5\/10 mg (ACEi)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/telma-h\/\">Telma H \u2014 Telmisartan + HCTZ combination<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/high-blood-pressure-medication\/\"><strong>Prohl\u00e9dnout v\u0161echny l\u00e9ky na vysok\u00fd krevn\u00ed tlak<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background: #fff3f3; border-left: 4px solid #d9534f; padding: 16px 20px; margin: 24px 0; border-radius: 4px;\"><strong>\u2695 Medical Disclaimer.<\/strong> This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Hypertension, heart failure, and arrhythmias require diagnosis, monitoring, and dose individualisation by a doctor \u2014 always use beta-blockers under medical guidance.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy<\/h3>\n<p>Dal\u0161\u00ed produkty v <strong>Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/robinax\/\">Robinax<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/affexor-xr\/\">Affexor XR<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/xyzal\/\">Xyzal<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/duolin-inhaler\/\">Duolin Inhaler<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/noltrexate\/\">Noltrexate<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Arkamin jsou tablety klonidinu 100 mcg od spole\u010dnosti Torrent Pharma \u2014 p\u016fvodn\u00ed centr\u00e1ln\u011b p\u016fsob\u00edc\u00ed agonista alfa-2 adrenergn\u00edch receptor\u016f (Catapres od Boehringer Ingelheim, 1966). Sni\u017euje centr\u00e1ln\u00ed sympatick\u00fd v\u00fddej; sni\u017euje perifern\u00ed noradrenalin o 30-50%. Pou\u017eit\u00ed: hypertenze \u010dtvrt\u00e9\/p\u00e1t\u00e9 linie, hypertenzn\u00ed urgentn\u00ed stavy, ADHD (v USA schv\u00e1leno jako Kapvay XR), abstinen\u010dn\u00ed p\u0159\u00edznaky u opioid\u016f a nikotinu, n\u00e1valy horka v menopauze, Tourett\u016fv syndrom, anestetick\u00e1 podpora. KRITICK\u00c9 \u2014 nikdy nep\u0159est\u00e1vejte n\u00e1hle (riziko rebound hypertenze s mo\u017enost\u00ed c\u00e9vn\u00ed mozkov\u00e9 p\u0159\u00edhody nebo infarktu myokardu).<\/p>","protected":false},"featured_media":51443,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[3357,3358],"class_list":{"0":"post-51442","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-arkamin","11":"product_tag-clonidine","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/51442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=51442"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/51443"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=51442"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=51442"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=51442"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=51442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}